These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 15735750

  • 1. TRAIL is a key target in S-phase slowing-dependent apoptosis induced by interferon-beta in cervical carcinoma cells.
    Vannucchi S, Chiantore MV, Fiorucci G, Percario ZA, Leone S, Affabris E, Romeo G.
    Oncogene; 2005 Apr 07; 24(15):2536-46. PubMed ID: 15735750
    [Abstract] [Full Text] [Related]

  • 2. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.
    Johnsen JI, Pettersen I, Ponthan F, Sveinbjørnsson B, Flaegstad T, Kogner P.
    Int J Oncol; 2004 Dec 07; 25(6):1849-57. PubMed ID: 15547726
    [Abstract] [Full Text] [Related]

  • 3. Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human cancer cells.
    Choi EA, Lei H, Maron DJ, Wilson JM, Barsoum J, Fraker DL, El-Deiry WS, Spitz FR.
    Cancer Res; 2003 Sep 01; 63(17):5299-307. PubMed ID: 14500361
    [Abstract] [Full Text] [Related]

  • 4. Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB.
    Yang X, Merchant MS, Romero ME, Tsokos M, Wexler LH, Kontny U, Mackall CL, Thiele CJ.
    Cancer Res; 2003 Mar 01; 63(5):1122-9. PubMed ID: 12615731
    [Abstract] [Full Text] [Related]

  • 5. Role of tumor necrosis factor-related apoptosis-inducing ligand in interferon-induced apoptosis in human bladder cancer cells.
    Papageorgiou A, Lashinger L, Millikan R, Grossman HB, Benedict W, Dinney CP, McConkey DJ.
    Cancer Res; 2004 Dec 15; 64(24):8973-9. PubMed ID: 15604261
    [Abstract] [Full Text] [Related]

  • 6. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.
    Chawla-Sarkar M, Leaman DW, Borden EC.
    Clin Cancer Res; 2001 Jun 15; 7(6):1821-31. PubMed ID: 11410525
    [Abstract] [Full Text] [Related]

  • 7. Interferon (IFN)-beta induces apoptotic cell death in DHL-4 diffuse large B cell lymphoma cells through tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Oehadian A, Koide N, Mu MM, Hassan F, Islam S, Yoshida T, Yokochi T.
    Cancer Lett; 2005 Jul 08; 225(1):85-92. PubMed ID: 15922860
    [Abstract] [Full Text] [Related]

  • 8. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
    Hesry V, Piquet-Pellorce C, Travert M, Donaghy L, Jégou B, Patard JJ, Guillaudeux T.
    Prostate; 2006 Jun 15; 66(9):987-95. PubMed ID: 16541419
    [Abstract] [Full Text] [Related]

  • 9. Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway.
    Chaturvedi V, Bodner B, Qin JZ, Nickoloff BJ.
    J Dermatol Sci; 2006 Jan 15; 41(1):31-41. PubMed ID: 16289694
    [Abstract] [Full Text] [Related]

  • 10. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P.
    Clin Cancer Res; 2006 Feb 15; 12(4):1355-64. PubMed ID: 16489094
    [Abstract] [Full Text] [Related]

  • 11. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis.
    Kim HS, Chang I, Kim JY, Choi KH, Lee MS.
    Cancer Res; 2005 Jul 15; 65(14):6111-9. PubMed ID: 16024612
    [Abstract] [Full Text] [Related]

  • 12. Interferon-gamma modulates TRAIL-mediated apoptosis in human colon carcinoma cells.
    Langaas V, Shahzidi S, Johnsen JI, Smedsrød B, Sveinbjørnsson B.
    Anticancer Res; 2001 Jul 15; 21(6A):3733-8. PubMed ID: 11911240
    [Abstract] [Full Text] [Related]

  • 13. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.
    Nakamoto N, Higuchi H, Kanamori H, Kurita S, Tada S, Takaishi H, Toda K, Yamada T, Kumagai N, Saito H, Hibi T.
    Int J Oncol; 2006 Sep 15; 29(3):625-35. PubMed ID: 16865278
    [Abstract] [Full Text] [Related]

  • 14. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.
    Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T.
    Cancer Res; 2005 Jul 15; 65(14):6364-70. PubMed ID: 16024639
    [Abstract] [Full Text] [Related]

  • 15. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

  • 16. Interferon-alpha-induced apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-dependent and -independent manner.
    Yanase N, Kanetaka Y, Mizuguchi J.
    Oncol Rep; 2007 Oct 07; 18(4):1031-8. PubMed ID: 17786370
    [Abstract] [Full Text] [Related]

  • 17. Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells.
    Lashinger LM, Zhu K, Williams SA, Shrader M, Dinney CP, McConkey DJ.
    Cancer Res; 2005 Jun 01; 65(11):4902-8. PubMed ID: 15930312
    [Abstract] [Full Text] [Related]

  • 18. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.
    Ou D, Wang X, Metzger DL, Robbins M, Huang J, Jobin C, Chantler JK, James RF, Pozzilli P, Tingle AJ.
    Hum Immunol; 2005 Jul 01; 66(7):799-809. PubMed ID: 16112027
    [Abstract] [Full Text] [Related]

  • 19. Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer.
    Mori T, Doi R, Toyoda E, Koizumi M, Ito D, Kami K, Kida A, Masui T, Kawaguchi Y, Fujimoto K.
    Surgery; 2005 Jul 01; 138(1):71-7. PubMed ID: 16003319
    [Abstract] [Full Text] [Related]

  • 20. Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand/anticancer drug combinations.
    Meurette O, Lefeuvre-Orfila L, Rebillard A, Lagadic-Gossmann D, Dimanche-Boitrel MT.
    Clin Cancer Res; 2005 Apr 15; 11(8):3075-83. PubMed ID: 15837763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.